Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
The European Respiratory Journal|February 26, 2021
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapyAndrew P Hearn, Oliver D Hug, Ziana A Somani, et al.
Thorax|December 27, 2022
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthmaHeath Heatley, Trung N Tran, Arnaud Bourdin, et al.
Pragmatic and Observational Research|March 20, 2024
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional AnalysisAndrew N Menzies-Gow, Trung N Tran, Brooklyn Stanley, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
The European Respiratory Journal|July 20, 2023
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthmaAlexandra M Nanzer, Victoria Taylor, Andrew P Hearn, et al.
The Journal of Allergy and Clinical Immunology. Global|March 25, 2024
Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United KingdomTrung N Tran, Heath Heatley, Jennifer Rowell, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2026
Early and Sustained Efficacy of Depemokimab in Type 2 Asthma: A Pooled Analysis of the SWIFT-1/-2 StudiesMichael E Wechsler, Ian D Pavord, Reynold A Panettieri, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 31, 2024
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With BenralizumabDavid J Jackson, Hassan Burhan, Hitasha Rupani, et al.
Microorganisms|January 23, 2020
Genomic Analysis of Carbapenemase<i>-</i>Producing Extensively Drug-Resistant <i>Klebsiella pneumoniae</i> Isolates Reveals the Horizontal Spread of p18-43_01 Plasmid Encoding <i>bla</i><sub>NDM-1</sub> in South AfricaYogandree Ramsamy, Koleka P Mlisana, Mushal Allam, et al.
Plos One|December 7, 2023
An examination of factorial invariance of the Asthma Control Questionnaire among adults with severe asthmaRonald McDowell, Liam Heaney, Thomas Brown, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
The European Respiratory Journal|February 26, 2021
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapyAndrew P Hearn, Oliver D Hug, Ziana A Somani, et al.
Thorax|December 27, 2022
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthmaHeath Heatley, Trung N Tran, Arnaud Bourdin, et al.
Pragmatic and Observational Research|March 20, 2024
Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional AnalysisAndrew N Menzies-Gow, Trung N Tran, Brooklyn Stanley, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch, et al.
The European Respiratory Journal|July 20, 2023
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthmaAlexandra M Nanzer, Victoria Taylor, Andrew P Hearn, et al.
The Journal of Allergy and Clinical Immunology. Global|March 25, 2024
Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United KingdomTrung N Tran, Heath Heatley, Jennifer Rowell, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2026
Early and Sustained Efficacy of Depemokimab in Type 2 Asthma: A Pooled Analysis of the SWIFT-1/-2 StudiesMichael E Wechsler, Ian D Pavord, Reynold A Panettieri, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 31, 2024
Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With BenralizumabDavid J Jackson, Hassan Burhan, Hitasha Rupani, et al.
Microorganisms|January 23, 2020
Genomic Analysis of Carbapenemase<i>-</i>Producing Extensively Drug-Resistant <i>Klebsiella pneumoniae</i> Isolates Reveals the Horizontal Spread of p18-43_01 Plasmid Encoding <i>bla</i><sub>NDM-1</sub> in South AfricaYogandree Ramsamy, Koleka P Mlisana, Mushal Allam, et al.
Plos One|December 7, 2023
An examination of factorial invariance of the Asthma Control Questionnaire among adults with severe asthmaRonald McDowell, Liam Heaney, Thomas Brown, et al.
Pageof 19